Court Upholds Ortho-McNeil's Topamax Patent
Mylan Laboratories Inc. suffered another setback in its battle to sell a generic version of the epilepsy drug Topamax, after a federal appeals court on Monday upheld a summary judgment ruling...To view the full article, register now.
Already a subscriber? Click here to view full article